841296-15-9

Usage

Uses

Used in Pharmaceutical Industry:
4-Amino-3-formyl-benzoic acid methyl ester is used as an intermediate in the synthesis of various pharmaceuticals. Its molecular structure and functional groups enable the development of new drugs with potential therapeutic applications. It serves as a key component in the production of active pharmaceutical ingredients, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical industry, 4-Amino-3-formyl-benzoic acid methyl ester is utilized as a precursor in the synthesis of agrochemicals, such as pesticides and herbicides. Its reactivity and functional groups allow for the creation of compounds with specific biological activities, enhancing crop protection and agricultural productivity.
Used in Drug Discovery:
4-Amino-3-formyl-benzoic acid methyl ester is employed as a starting material in drug discovery research. Its unique molecular structure and properties make it a valuable candidate for the development of novel therapeutic agents. Researchers can modify and functionalize 4-Amino-3-formyl-benzoic acid methyl ester to explore its potential in treating various diseases and medical conditions.
Used in Organic Reactions:
As a versatile building block, 4-Amino-3-formyl-benzoic acid methyl ester is used in various organic reactions to synthesize complex organic compounds. Its reactivity and functional groups facilitate the formation of new chemical entities, expanding the scope of organic chemistry and contributing to the discovery of new materials and compounds with diverse applications.

Upstream product

• 148625-35-8 methyl 3-formyl-4-nitrobenzoate 
• 841296-14-8 4-amino-3-dimethoxymethyl-benzoic acid methyl ester 

Downstream Products

• 841296-42-2 2-[4'-chloro-4-(pyrrolidine-1-carbonyl)-biphen-2-yl]-quinoline-6-carboxylic acid 
• 841296-38-6 2-[2-hydroxy-5-(pyrrolidine-1-carbonyl)-phenyl]-quinoline-6-carboxylic acid 
• 1315578-07-4 methyl 2-phenylquinazoline-6-carboxylate 
• 1315578-13-2 methyl 2-p-tolylquinazoline-6-carboxylate 
• 1036755-96-0 methyl 2-chloroquinazoline-6-carboxylate 
• 1395473-89-8 (S)-methyl 2-(4-methoxyphenyl)-1,2,3,4-tetrahydroquinoline-6-carboxylate 

Relevant academic research and scientific papers

INHIBITORS OF ENL/AF9 YEATS

Methods and compositions for treating leukemia are disclosed. Acylated 6-aminoindoles, acylated 6-aminopyrrolopyridines and acylated 3-aminopyrrolo[3,2-c]pyridazines of the following formula inhibit ENL/AF9 YEATS and are therefore useful for treating leukemia.

SMALL MOLECULE INHIBITION OF SULFOTRANSFERASE SULT1A3

Provided herein are small molecule compounds and methods inhibiting human sulfotransferase 1A3 (SULT1A3) using these small molecule compounds. Methods of manufacturing and treatment are also disclosed.

Gold(I)-catalyzed unprecedented rearrangement reaction between 2-aminobenzaldehydes with propargyl amines: An expedient route to 3-aminoquinolines

Access to aminoquinolines: A gold(I)-catalyzed unprecedented rearrangement reaction between 2-aminobenzaldehydes with propargyl amine was studied. The study provided, for the first time, direct access to 3-aminoquinolines in one step starting from readily available starting materials (see scheme). Elegantly designed experiments were employed to unravel the mechanism of this unprecedented rearrangement, which are corroborated by DFT calculations.

Novel CGRP receptor antagonists from central amide replacements causing a reversal of preferred chirality

A previously utilized quinoline-for-N-phenylamide replacement strategy was employed against a central amide in a novel class of CGRP receptor antagonists. A unique and unexpected substitution pattern was ultimately required to maintain reasonable affinity

α-amination of nitrogen heterocycles: Ring-fused aminals

Aromatic aminoaldehydes react with cyclic amines to produce ring-fused aminals under thermal conditions. This process is applied to two-step syntheses of the quinazolinone alkaloids deoxyvasicinone and rutaecarpine. Copyright

BICYCLIC IMIDAZOL DERIVATIVES AGAINST FLAVIVIRIDAE

Disclosed are compounds, compositions and methods for treatingFlaviviridae family virus infections.